&nbsp;

FNIM_how-we-collect-cancer-information-in-Ontario.jpg

Dec 2017

Document

FNIM_prevalence.jpg

Dec 2017

Document

FNIM_mortality.jpg

Dec 2017

Document

FNIM_incidence.jpg

Dec 2017

Document

FNIM_comparing-cancer-in-different-populations.jpg

Dec 2017

Document

FNIM_introduction.jpg

Dec 2017

Regimen

FLAG

Cancer Type:

Hematologic,

Leukemia - Acute Lymphoblastic (ALL),

Leukemia - Acute Myeloid (AML)

Intent: Palliative

Drugs Used:

fludarabine,

cytarabine

... Show more tags

Quick Link(s):

Regimen Monograph

May 2019

Cancer facts

Female thyroid cancer incidence varies across geographic regions in Ontario

Jul 2018

Document

2018 CSRT CoP Annual Report

Aug 2018

Regimen

FC+OBIN

Cancer Type:

Hematologic,

Lymphoma - Non-Hodgkin's Low Grade

Intent: Palliative

Funding:

New Drug Funding Program

Obinutuzumab - In Combination with Chemotherapy for Refractory Follicular Lymphoma

Drugs Used:

Quick Link(s):

Regimen Monograph

Jun 2021

Regimen

FC(PO)+OBIN

Cancer Type:

Hematologic,

Lymphoma - Non-Hodgkin's Low Grade

Intent: Palliative

Funding:

New Drug Funding Program

Obinutuzumab - In Combination with Chemotherapy for Refractory Follicular Lymphoma

ODB - General Benefit

cyclophosphamide - oral tablets

Drugs Used:

oBINutuzumab,

fludarabine (Unfunded),

cyclophosphamide

... Show more tags

Quick Link(s):

Regimen Monograph

May 2019

Regimen

FCM(PO)+OBIN

Cancer Type:

Hematologic,

Lymphoma - Non-Hodgkin's Low Grade

Intent: Palliative

Funding:

New Drug Funding Program

Obinutuzumab - In Combination with Chemotherapy for Refractory Follicular Lymphoma

ODB - General Benefit

cyclophosphamide - oral tablets

Drugs Used:

oBINutuzumab,

mitoXANTRONE,

fludarabine (Unfunded),

cyclophosphamide

... Show more tags